Loading fund overlap…
13 of 96 unique stocks in common · Jaccard: 13.5%
A weighted portfolio overlap of 18.44% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹18.44 is allocated to the exact same companies at the same relative proportions. The schemes share 13 common holdings.
The largest overlapping asset in their portfolios is Infosys, which commands a weight of 7.66% in Tata Ethical Fund and 3.76% in UTI Nifty 50 ETF. Holding both schemes increases your concentration in Infosys rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Tata | in UTI |
|---|---|---|
| InfosysIT - Software | 7.66% | 3.76% |
| Tata Consultancy ServicesIT - Software | 5.60% | 2.13% |
| Hindustan UnileverDiversified FMCG | 3.27% | 1.77% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 2.24% | 1.76% |
| Hindalco IndustriesNon - Ferrous Metals | 2.41% | 1.51% |
| Ultratech CementCement & Cement Products | 2.52% | 1.26% |
| HCL TechnologiesIT - Software | 2.95% | 1.15% |
| Asian PaintsConsumer Durables | 1.23% | 1.12% |
| Nestle IndiaFood Products | 2.01% | 0.94% |
| Tech MahindraIT - Software | 3.51% | 0.87% |
| CiplaPharmaceuticals & Biotechnology | 2.38% | 0.73% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 2.40% | 0.73% |
| Tata Consumer ProductsAgricultural Food & Other Products | 0.82% | 0.71% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.